APA (7th ed.) Citation

Manara, M. C., Bruzzese, F., Formentini, L., Landuzzi, L., Pazzaglia, L., Laginestra, M. A., . . . Righi, A. (2025). Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma. Journal of Experimental & Clinical Cancer Research (17569966), 44(1), 1. https://doi.org/10.1186/s13046-025-03440-5

Chicago Style (17th ed.) Citation

Manara, Maria Cristina, et al. "Genomic Profiling of a Collection of Patient-derived Xenografts and Cell Lines Identified Ixabepilone as an Active Drug Against Chemo-resistant Osteosarcoma." Journal of Experimental & Clinical Cancer Research (17569966) 44, no. 1 (2025): 1. https://doi.org/10.1186/s13046-025-03440-5.

MLA (9th ed.) Citation

Manara, Maria Cristina, et al. "Genomic Profiling of a Collection of Patient-derived Xenografts and Cell Lines Identified Ixabepilone as an Active Drug Against Chemo-resistant Osteosarcoma." Journal of Experimental & Clinical Cancer Research (17569966), vol. 44, no. 1, 2025, p. 1, https://doi.org/10.1186/s13046-025-03440-5.